Overexpression of FGL1 reduces the activity of the nuclear factor kappa B (NF-κB) pathway, thereby attenuating RA injury by inhibiting apoptosis of fibroblast-like synoviocytes (FLS) and promoting their proliferation (29). The gene discussed is FGL1; the disease is rheumatoid arthritis.